HIV treatment adherence, patient health literacy, and health care provider-patient communication: Results from the 2010 AIDS Treatment for Life International Survey

Jean B. Nachega, Chelsea Morroni, José M. Zuniga, Mauro Schechter, Jürgen Rockstroh, Suniti Solomon, Renslow Sherer

Research output: Contribution to journalArticlepeer-review

33 Scopus citations

Abstract

Background: Little is known about patients' health literacy regarding antiretroviral therapy (ART) adherence and drug resistance and patient-provider communication about these topics. Design and Methods: The AIDS Treatment for Life International Survey was a multicountry cross-sectional study (January-March 2010) including 2035 HIV-infected adults. A 40-minute interview was conducted using a standardized self-report adherence questionnaire. Results: Overall, 57% of patients reported a 30-day recall of 100% adherence (Latin America: 89%; Africa: 73% vs North America: 45% and Asia Pacific: 47%; P <.01). Overall, 18% identified HIV drug resistance as a "good thing" in North America (35%) and Africa (24%). Only 71% said their health care providers had offered practical recommendations about adherence, 62% of the patients in North America and 80% in Latin America and Africa. Conclusions: Optimal ART adherence remains a challenge globally. There is a critical need to improve patient-provider communication about the importance of ART adherence and its benefits for patient's health.

Original languageEnglish (US)
Pages (from-to)128-133
Number of pages6
JournalJournal of the International Association of Physicians in AIDS Care
Volume11
Issue number2
DOIs
StatePublished - Mar 2012
Externally publishedYes

Keywords

  • HIV
  • adherence
  • antiretroviral therapy
  • communication
  • drug resistance
  • patient-physician

ASJC Scopus subject areas

  • Immunology
  • Dermatology
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'HIV treatment adherence, patient health literacy, and health care provider-patient communication: Results from the 2010 AIDS Treatment for Life International Survey'. Together they form a unique fingerprint.

Cite this